Publication | Closed Access

Overexpression of vascular endothelial growth factor (VEGF) and its cellular receptor KDR (VEGFR-2) in the bone marrow of patients with acute myeloid leukemia

Hematological MalignancyHealth SciencesMixed-phenotype Acute LeukemiaAcute Myeloid LeukemiaMalignant Blood DisorderHematologyImmunologyPathologyMyeloid NeoplasiaBone MarrowVascular BiologyVascular Endothelial Growth FactorMedicineCellular Receptor Kdr